Order Entry
United States
ContactUsLinkComponent
Prostate Cancer Plasma, Charles River Laboratories Cell Solutions
Prostate Cancer Plasma, Charles River Laboratories Cell Solutions
Catalog # 103051-112
CAS Number:  
Prostate Cancer Plasma, Charles River Laboratories Cell Solutions
Catalog # 103051-112
Supplier Number:  PB006C-1-PC
CAS Number:  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

  • • State issued document with your organization's Federal Tax ID Number
  • • State issued document with your organization's Resale Tax ID Number
  • • City or County issued Business License
  • • State Department of Health Services License
  • • Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.

Specifications

  • Pack type:
    Cryopreserved
  • Description:
    Prostate Cancer Plasma
  • Size:
    2 mL
  • Environmentally Preferable:
  • Cat. No.:
    103051-112
  • Supplier no.:
    PB006C-1-PC

Specifications

About this item

Plasma is collected from IRB-consented volunteer donors diagnosed with Prostate Cancer.

  • Used for research
  • Causes, diagnosis, care and treatment of prostate cancer
  • Collected from volunteer donors

Plasma is used for researching the causes, diagnosis, supportive care and treatment of Prostate Cancer (PC), the most common type of cancer in men

Collected from IRB consented prostate cancer (PC) volunteer donors.

Treatment for prostate cancer is a very active area of research, where newer treatments are being developed, and improvements are being made among many standard prostate cancer treatment methods.